GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chongqing Genrix Biopharmaceutical Co Ltd (SHSE:688443) » Definitions » Other Gross PPE

Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Other Gross PPE : ¥426.39 Mil (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Chongqing Genrix Biopharmaceutical Co Other Gross PPE?

Chongqing Genrix Biopharmaceutical Co's Other Gross PPE for the quarter that ended in Mar. 2025 was ¥426.39 Mil.

Chongqing Genrix Biopharmaceutical Co's quarterly Other Gross PPE increased from Sep. 2024 (¥402.78 Mil) to Dec. 2024 (¥434.81 Mil) but then declined from Dec. 2024 (¥434.81 Mil) to Mar. 2025 (¥426.39 Mil).

Chongqing Genrix Biopharmaceutical Co's annual Other Gross PPE increased from Dec. 2022 (¥149.45 Mil) to Dec. 2023 (¥153.50 Mil) and increased from Dec. 2023 (¥153.50 Mil) to Dec. 2024 (¥434.81 Mil).


Chongqing Genrix Biopharmaceutical Co Other Gross PPE Historical Data

The historical data trend for Chongqing Genrix Biopharmaceutical Co's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Genrix Biopharmaceutical Co Other Gross PPE Chart

Chongqing Genrix Biopharmaceutical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial 103.20 139.10 149.45 153.50 434.81

Chongqing Genrix Biopharmaceutical Co Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 431.02 153.66 402.78 434.81 426.39

Chongqing Genrix Biopharmaceutical Co Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Chongqing Genrix Biopharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 699, Maliu Avenue, Area A, Building 2, International Bio City, Banan, Chongqing, CHN, 401338
Chongqing Genrix Biopharmaceutical Co Ltd is engaged in the research & development, production and sales of antibody drugs. The company has a total of more than ten products under research covering three major therapeutic areas. The progress of core products is leading, and some product pipelines are as follows; autoimmune disease, infectious disease, and tumor. Its product Xeligekimab injection (Xeligekimab) is a recombinant fully human anti-IL-17A monoclonal antibody independently developed by the company, which has been accepted by the National Medical Products Administration (NMPA) for new drug marketing applications.
Executives
Jiang Ren Sheng Director

Chongqing Genrix Biopharmaceutical Co Headlines

No Headlines